Your browser doesn't support javascript.
loading
Reduced moxifloxacin exposure in patients with tuberculosis and diabetes.
Dekkers, Bart G J; Bolhuis, Mathieu S; Ter Beek, Lies; de Lange, Wiel C M; van der Werf, Tjip S; Alffenaar, Jan-Willem C; Akkerman, Onno W.
Afiliación
  • Dekkers BGJ; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands b.g.j.dekkers@umcg.nl.
  • Bolhuis MS; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Ter Beek L; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • de Lange WCM; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
  • van der Werf TS; Hanze University of Applied Sciences, Nutrition and Dietetics, Groningen, The Netherlands.
  • Alffenaar JC; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Akkerman OW; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
Eur Respir J ; 54(3)2019 09.
Article en En | MEDLINE | ID: mdl-31048350

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Diabetes Mellitus / Moxifloxacino / Antituberculosos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Diabetes Mellitus / Moxifloxacino / Antituberculosos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos